Search

everythinglearnresearchcommunity

for

Search:↓

Care for gender-dysphoric Veterans can be improved with a consistent, team-based approach.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Stress can worsen skin conditions by affecting hormone levels and immune response.

The healthcare for transgender veterans could be better with a more unified team approach.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

Quercetin may help with PCOS symptoms, but more research is needed.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

PCOS has many symptoms, with high androgen levels being the most common.

Addressing skin changes during pregnancy is important to reduce stress for expectant mothers.

A single steroid injection can cause serious side effects like Cushing Syndrome.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.